Clinical Proteomics for the Benefit of Patients
The official congress theme ‘Clinical Proteomics for the Benefit of the Patients’ brings together biopharma and biotech drug developments, for the first time involving Pharma Industry in one of the foremost arenas for the advancement of life sciences – a natural next step considering that knowledge derived from proteomics research is playing an increasingly important role in drug development.
Join us in Stockholm, Sweden to learn more about:
- systems biology.
- disease areas such as; oncology, cardiovascular diseases, pulmonary diseases, neurodegenerative diseases, and infection/immunology.
- biomarkers and diagnostics that can aid in selecting optimal drug choice and use for patient benefit.
Registration for the 2020 HUPO World Congress will open soon.